RecruitingNot ApplicableNCT03917056

Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse

Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse: a Nationwide Multicenter Randomized Controlled Trial


Sponsor

The Second Hospital of Nanjing Medical University

Enrollment

1,000 participants

Start Date

Jun 24, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial aims to evaluate the efficacy and safety of long needle and short needle in the treatment of internal hemorrhoids and rectal prolapse through CAES (Cap-assisted endoscopic sclerotherapy).


Eligibility

Inclusion Criteria2

  • Patients with internal hemorrhoids and rectal prolapse, combined with external hemorrhoids or without external hemorrhoids.
  • Patients with bowel preparation.

Exclusion Criteria6

  • History of anoscopic/endoscopic sclerotherapy.
  • Patients with acute thrombotic external hemorrhoids.
  • Patients with serious internal hemorrhoids of grade IV.
  • Patients with anal stenosis, anal fissure, fistula, fecal incontinence, ulcerative colitis, Crohn's disease.
  • Patients with acute diarrhea in the past 24 hours.
  • Hypertensive patients with uncontrolled blood pressure, patients with cerebrovascular accident and obvious bleeding tendency, pregnant women, mental disorders and decompensated cirrhosis.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURECap-assisted endoscopic sclerotherapy using long needle

Participants were treated with CAES using long needle.

PROCEDURECap-assisted endoscopic sclerotherapy using short needle

Participants were treated with CAES using short needle.


Locations(1)

Fmt-Dt-N-27/1350

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03917056


Related Trials